Skip to content

Distress Tolerance Treatment for Substance Users

Distress Tolerance Treatment for Substance Users

Status
UNKNOWN
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01741415
Enrollment
325
Registered
2012-12-04
Start date
2013-05-13
Completion date
2019-09-01
Last updated
2018-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Substance Dependence

Brief summary

Despite recent advances in substance abuse interventions, a large percentage of clients entering residential treatment for substance use will drop out of treatment prematurely, and of the remaining, many will relapse soon after treatment completion. Previous research indicates that an individual's ability to withstand psychological distress is a key factor necessary to maintain drug and alcohol abstinence and to remain in substance use treatment without absconding. In previous work, Dr. Bornovalova developed a specific distress tolerance treatment called Skills for Improving Distress Intolerance (SIDI). This intervention features skills training in behavioral and acceptance strategies and intentional clinical exposure to emotional distress. SIDI was developed and piloted with a sample of urban drug users seeking treatment in a residential facility. Individuals receiving SIDI exhibited greater improvement in distress tolerance than those in two comparison groups (receiving treatment-as-usual and supportive counseling). Current study. The investigators received NIDA funding to conduct a randomized clinical trial with 325 clients entering a residential substance use treatment facility. Study participants will be randomized into two treatment groups: (1) those receiving SIDI and (2) those receiving Supportive Counseling (SC). Participants will receive 10 treatment sessions over a period of 4 months. Then, the investigators will follow clients for one year to examine treatment retention and abstinence.

Interventions

BEHAVIORALSIDI
BEHAVIORALSC

Sponsors

University of South Florida
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* 18-65 years of age * Not evidencing severe cognitive deficits * Ability to give informed consent

Exclusion criteria

* \<18 years of age or \> 65 years of age * Not evidencing severe cognitive deficits (site designation of 'not competent to stand trial') * Unable to give informed consent

Design outcomes

Primary

MeasureTime frameDescription
abstinence at 1, 3, 6 & 12 month follow-up1, 3, 6 month follow-up post-treatmentMeasured via biological verification and timeline follow-back

Secondary

MeasureTime frameDescription
distress tolerance1, 3, 6 month follow-upability to tolerate psychological distress

Other

MeasureTime frameDescription
successful/unsuccessful completion of residential addictions treatmentBaseline, post-treatment (at 3 month mark in residential facility), successful discharge within 6 months from residential facilitysuccessful/unsuccessful completion of residential addictions treatment
time in jail1, 3, 6 month follow-up in communitymeasured by public records (# of days in jail by each timepoint)
psychiatric distresspost-treatment at 3 month mark in residential facility, 1, 3, 6 month follow-up in communitypsychiatric distress on brief symptom inventory
maladaptive personalitypost-treatment (at 3 month mark in residential facility), 1, 3, 6 month follow-up in communitychange in maladaptive personality on the Personality Inventory for DSM5

Countries

United States

Contacts

Primary ContactKelly Lane, BA
kellylane@mail.usf.edu813-974-9030
Backup ContactMarina Bornovalova, PhD
bornovalova@usf.edu3123990983

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026